These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 5005219

  • 1. HL-A antibodies: influence on the human foetus.
    Ahrons S.
    Tissue Antigens; 1971; 1(3):129-36. PubMed ID: 5005219
    [No Abstract] [Full Text] [Related]

  • 2. Haemolytic disease of the newborn due to Rh-isoimmunization: the role of free anti-D antibodies in bilirubin rebound.
    Pataki L.
    Acta Paediatr Acad Sci Hung; 1970; 11(3):219-29. PubMed ID: 5004392
    [No Abstract] [Full Text] [Related]

  • 3. Irregular antibodies in the obstetric patient.
    Queenan JT, Smith BD, Haber JM, Jeffrey J, Gadow HC.
    Obstet Gynecol; 1969 Dec; 34(6):767-71. PubMed ID: 4983579
    [No Abstract] [Full Text] [Related]

  • 4. [Occurrence of cytotoxic anti-HL-A antibodies in female patients sensitized to Rh antigens].
    Susaković N, Matejić T, Marković V, Stolić I.
    Bilt Hematol Transfuz; 1976 Dec; 4(3):17-21. PubMed ID: 827282
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Incidence of materno-fetal isoimmunization against the Rh factor (D)].
    Marmorino C.
    Minerva Med; 1972 Dec 01; 63(86):4699-707. PubMed ID: 4629911
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Management of pregnancy complicated by Rh-immunization. Review with respect to own investigations and results.
    Bartsch FK.
    Pathologica; 1972 Dec 01; 64(929):139-48. PubMed ID: 4210413
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The performance of an anti D immunoprophylaxis scheme.
    Kinnock S, Liley AW.
    N Z Med J; 1974 Oct 23; 80(526):337-43. PubMed ID: 4216865
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Our experience with the pre- and postnatal diagnosis of ABO-hemolytic disease of the newborn].
    Novachev D, Markov L, Antonov L, Tankov Ts.
    Akush Ginekol (Sofiia); 1977 Oct 23; 16(5):317-26. PubMed ID: 413455
    [No Abstract] [Full Text] [Related]

  • 17. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV, Beck ML.
    Clin Haematol; 1984 Feb 23; 13(1):167-83. PubMed ID: 6327130
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Value of immunologic tests in the hemolytic disease of the newborn in ABO incompatibility].
    Kourteva B, Doitchinova N, Chinkov D.
    Nouv Rev Fr Hematol; 1968 Feb 23; 8(6):892-4. PubMed ID: 4236876
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.